Trial
NCT06608940
BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Case Comprehensive Cancer Center
Collaborators
—
Condition
Hepato Cellular Carcinoma (HCC)
Intervention
BC3402
Why stopped
Funding unavailable
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-19